July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
The Ca2+/ Nucleotide Nanocomplex formulation enhances the pump function of corneal endothelial cells by increasing the activity of Na+/K+ Dependent ATPase.
Author Affiliations & Notes
  • Su Ah Kim
    Department of Ophthalmology, SahmYook Medical Center, Seoul, Korea (the Republic of)
  • Ramsha Afzal
    Department of Ophthalmology, Incheon St. Mary’s Hospital, Incheon, Korea (the Republic of)
  • Hyung Bin Hwang
    Department of Ophthalmology, Incheon St. Mary’s Hospital, Incheon, Korea (the Republic of)
  • Byung Su Lim
    Department of Ophthalmology, Incheon St. Mary’s Hospital, Incheon, Korea (the Republic of)
  • Jae Gyun Jeung
    Department of Ophthalmology, Incheon St. Mary’s Hospital, Incheon, Korea (the Republic of)
  • Kui Dong Kang
    Department of Ophthalmology, Incheon St. Mary’s Hospital, Incheon, Korea (the Republic of)
  • Footnotes
    Commercial Relationships   Su Ah Kim, None; Ramsha Afzal, None; Hyung Bin Hwang, None; Byung Su Lim, None; Jae Gyun Jeung, None; Kui Dong Kang, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 1371. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Su Ah Kim, Ramsha Afzal, Hyung Bin Hwang, Byung Su Lim, Jae Gyun Jeung, Kui Dong Kang; The Ca2+/ Nucleotide Nanocomplex formulation enhances the pump function of corneal endothelial cells by increasing the activity of Na+/K+ Dependent ATPase.. Invest. Ophthalmol. Vis. Sci. 2018;59(9):1371.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Na, K-ATPase exist in the membrane of the corneal endothelial cell and control the corneal hydration through the pump function. It also plays an important role in preserving the transparency of the cornea. In this study, we investigated the effect of Ca2+/ Nucleotide (NT) nanocomplex (NC) on Na, K-ATPase and the pump function of the corneal endothelial cells.

Methods : Bovine corneal endothelial cells were used, and the cells were treated with Ca2+/ Nucleotide (NT) nanocomplex (NC) formulation after various insults. Na, K-ATPase activity was measured by the spectrophotometric measurement of phosphate released from ATP with the use of ammonium molybdate. The Na, K-ATPase activity was calculated as the difference in ATPase activity between cells exposed to ouabain and those not exposed. Ussing chamber was used to measure the pump function of endothelial cells. Western blot analysis and immunocytochemistry were performed to measure the expression of Na, K-ATPase α1 subunit.

Results : The Ca2+ NT NCs were prepared at a [Ca2+]:[NT]:[bPEI 1.8kDa] ratio of 0.25 mM: 0.5 mM: 1.0 mM and these preparations significantly and gradually increased the activity of Na, K-ATPase in cultured bovine corneal endothelial cells. And these effects were effectively blocked by the PKC inhibitor (protein kinase C). In addition, Ca2+ NT NCs (0.25 mM and 0.5 mM) increased the viability of cells exposed to a low temperature (4°C) for 4 or 8 hours in a serum containing medium (p<0.05). Western blot analysis indicated that Ca2+ NT NCs formulation significantly decreased the ratio of inactive Na, K-Atpase α1 subunit (after 12 hours of incubation with 0.5 mM of Ca2+ NT NCs formation). Immunocytochemistry reveals that Ca2+ NT NCs formulation increased the cell surface expression of the Na,K-ATPase α1 subunit.

Conclusions : This study demonstrates that the Ca2+ NT NC formulation increases the activity of Na, K-ATPase in the corneal endothelial cells to enhance the pump function. Our results imply a potential therapeutic strategy that the pumping function of the corneal endothelial cells can be improved by the administration of Ca2+ NT NC formulation, which may help to maintain and improve transparency of the cornea. Further experiments are to be carried out to confirm the practical effect of the Ca2+ NT NC formulation in vivo.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×